December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported ...

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities. The below ...

The ostomy care accessory market in North America is ... Inc., Perfect Choice Medical Technologies, Fortis Medical Products, AdvaCare Pharma, Schena Ostomy Technologies, Inc., Cymed.

It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions ...

The stoma/ostomy care market is projected to grow at a 4.9% CAGR, reaching USD 6.5 billion by 2033. The rising prevalence of ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Tuesday, February 04 based on AAII’s Stock Grades.

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Elaine Hinzey is a registered dietitian and the Assistant Managing Editor for the Advice Products team in the ... Savvy Gal and The Journal of Wound and Ostomy Management. She also co-authored ...